FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

MCLAUGHLIN JOHN PETER
2. Issuer Name and Ticker or Trading Symbol

ROCKWELL MEDICAL, INC. [ RMTI ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O ROCKWELL MEDICAL, INC., 30142 WIXOM ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

9/5/2019
(Street)

WIXOM, MI 48393
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  9/5/2019    A(1)    22559  A $0  22559  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  $2.560  9/5/2019    A     28372       (2) 9/5/2029  Common Stock  28372  $0  28372  D   

Explanation of Responses:
(1)  Restricted stock units vest on June 6, 2020, subject to the Reporting Person's continued service to the Issuer.
(2)  Stock options vest on June 6, 2020, subject to the Reporting Person's continued service to the Issuer.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
MCLAUGHLIN JOHN PETER
C/O ROCKWELL MEDICAL, INC.
30142 WIXOM ROAD
WIXOM, MI 48393
X



Signatures
/s/ Michael G. Costello, Attorney-in-Fact for John P. McLaughlin 9/6/2019
**Signature of Reporting Person Date


Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Rockwell Medical Charts.
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Rockwell Medical Charts.

Rockwell Medical, Inc. News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States
Wednesday 17 April 2024 (2 weeks ago) • Business Wire
Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024
Tuesday 16 April 2024 (3 weeks ago) • Business Wire
Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda
Thursday 4 April 2024 (1 month ago) • Business Wire
Rockwell Medical Named 'Great Place to Work' for Second Year in a Row
Monday 25 March 2024 (1 month ago) • Business Wire
Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023
Thursday 21 March 2024 (1 month ago) • Business Wire
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)
Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024
Thursday 8 February 2024 (3 months ago) • Business Wire
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)
Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund
Monday 8 January 2024 (4 months ago) • Business Wire
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 14 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 14 November 2023 (6 months ago) • Edgar (US Regulatory)